Compare $BIAF vs $CELZ | Chartloom

Compare

$BIAF vs $CELZ

bioAffinity Technologies Inc · Creative Medical Technology Holdings Inc

BIAF

bioAffinity Technologies Inc

CELZ

Creative Medical Technology Holdings Inc

Compare $BIAF vs $CELZ

Comparing bioAffinity Technologies Inc and Creative Medical Technology Holdings Inc

BIAFbioAffinity Technologies Inc

CELZCreative Medical Technology Holdings Inc

BIAFbioAffinity Technologies Inc

Market cap

$37M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-23.2%

YTD performance

-74.2%

52W performance

-89.7%

FCF yield

-31.5%

CELZCreative Medical Technology Holdings Inc

Market cap

$4M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-50.0%

YTD performance

-57.4%

52W performance

-76.5%

FCF yield

-148.5%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

BIAF

CELZ

Detailed metrics comparison

BIAF

bioAffinity Technologies Inc

CELZ

Creative Medical Technology Holdings Inc

Market Cap

BIAF$37M

CELZ$4M

Enterprise Value

BIAF$35M

CELZ$-5M

Price

BIAF$4.73

CELZ$0.84

P/E Ratio

BIAFN/A

CELZN/A

P/S Ratio

BIAF6.23x

CELZ1,324.83x

EV/Sales

BIAF5.93x

CELZ-1,579.87x

EV/EBITDA

BIAF0.00x

CELZ0.00x

P/B Ratio

BIAF1.87x

CELZ0.72x

P/FCF Ratio

BIAFN/A

CELZN/A

EV/FCF

BIAF-3.02x

CELZ0.80x

PEG Ratio

BIAFN/A

CELZN/A

Forward P/E (NTM)

BIAFN/A

CELZN/A

Forward P/S (NTM)

BIAFN/A

CELZN/A

Revenue (TTM)

BIAF$6M

CELZ$3K

Revenue Growth (YoY)

BIAF-23.2%

CELZ-50.0%

Forward Rev Growth

BIAF0.0%

CELZ56.2%

Gross Margin (TTM)

BIAF34.6%

CELZ66.7%

Operating Margin (TTM)

BIAF0.0%

CELZ0.0%

EBITDA Margin (TTM)

BIAF-202.8%

CELZ-204213.3%

Net Margin (TTM)

BIAF-257.3%

CELZ-201356.7%

FCF Margin (TTM)

BIAF-196.0%

CELZ-196726.7%

Net Income (TTM)

BIAF$-15M

CELZ$-6M

FCF (TTM)

BIAF$-12M

CELZ$-6M

EPS (TTM)

BIAF-$43.57

CELZ-$1.63

ROE (TTM)

BIAF-25727.0%

CELZ-8670.0%

ROA (TTM)

BIAF-15954.0%

CELZ-8196.0%

ROIC (TTM)

BIAF-23305.0%

CELZ-8670.0%

Cash

BIAF$2M

CELZ$9M

Debt

BIAF$634K

CELZ$0

Net Cash/Debt

BIAF$2M

CELZ$9M

Current Ratio (TTM)

BIAF1.44x

CELZ12.91x

Quick Ratio (TTM)

BIAF1.36x

CELZ12.63x

Debt/Equity (TTM)

BIAF0.17x

CELZ0.00x

Debt/Assets (TTM)

BIAF0.0%

CELZ0.0%

Interest Coverage (TTM)

BIAFN/A

CELZN/A

Net Debt/EBITDA (TTM)

BIAF0.00x

CELZ0.00x

Beta

BIAF-1.26

CELZ1.93

52W Performance

BIAF-89.7%

CELZ-76.5%

YTD Performance

BIAF-74.2%

CELZ-57.4%

% from 52W High

BIAF-94.1%

CELZ-86.6%

% from 52W Low

BIAF3.6%

CELZ35.2%

Asset Turnover (TTM)

BIAF0.62x

CELZ0.00x

FCF Yield (TTM)

BIAF-31.5%

CELZ-148.5%

Earnings Yield (TTM)

BIAF-41.3%

CELZ-152.0%

Dividend Yield (TTM)

BIAFN/A

CELZN/A

Rule of 40

BIAF-219.2

CELZ-196,776.7

EV/GP/RG

BIAFN/A

CELZN/A

Ticker research

View BIAF research View CELZ research

Metric	BIAF bioAffinity Technologies Inc	CELZ Creative Medical Technology Holdings Inc
Market & Valuation
Market Cap	$37M	$4M
Enterprise Value	$35M	$-5M
Price	$4.73	$0.84
P/E Ratio	N/A	N/A
P/S Ratio	6.23x	1,324.83x
EV/Sales	5.93x	-1,579.87x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.87x	0.72x
P/FCF Ratio	N/A	N/A
EV/FCF	-3.02x	0.80x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$6M	$3K
Revenue Growth (YoY)	-23.2%	-50.0%
Forward Rev Growth	0.0%	56.2%
Profitability
Gross Margin (TTM)	34.6%	66.7%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-202.8%	-204213.3%
Net Margin (TTM)	-257.3%	-201356.7%
FCF Margin (TTM)	-196.0%	-196726.7%
Net Income (TTM)	$-15M	$-6M
FCF (TTM)	$-12M	$-6M
EPS (TTM)	-$43.57	-$1.63
ROE (TTM)	-25727.0%	-8670.0%
ROA (TTM)	-15954.0%	-8196.0%
ROIC (TTM)	-23305.0%	-8670.0%
Financial Health
Cash	$2M	$9M
Debt	$634K	$0
Net Cash/Debt	$2M	$9M
Current Ratio (TTM)	1.44x	12.91x
Quick Ratio (TTM)	1.36x	12.63x
Debt/Equity (TTM)	0.17x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-1.26	1.93
52W Performance	-89.7%	-76.5%
YTD Performance	-74.2%	-57.4%
% from 52W High	-94.1%	-86.6%
% from 52W Low	3.6%	35.2%
Efficiency & Yields
Asset Turnover (TTM)	0.62x	0.00x
FCF Yield (TTM)	-31.5%	-148.5%
Earnings Yield (TTM)	-41.3%	-152.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-219.2	-196,776.7
EV/GP/RG	N/A	N/A
Ticker research	View BIAF research	View CELZ research

Valuation

P/S Ratio

BIAF

6.23x

CELZ

1,324.83x

EV/FCF

BIAF

-3.02x

CELZ

0.80x

Growth & revenue

Revenue Growth TTM

BIAF

-23.2%

CELZ

-50.0%

Forward Revenue Growth

CELZ

56.2%

BIAF

0.0%

Profitability & performance

Gross Margin

CELZ

66.7%

BIAF

34.6%

ROE

CELZ

-8670.0%

BIAF

-25727.0%

FCF Yield %

BIAF

-31.5%

CELZ

-148.5%

52-Week Performance

CELZ

-76.5%

BIAF

-89.7%

Detailed metrics comparison

BIAF

bioAffinity Technologies Inc

CELZ

Creative Medical Technology Holdings Inc

Market Cap

BIAF$37M

CELZ$4M

Enterprise Value

BIAF$35M

CELZ$-5M

Price

BIAF$4.73

CELZ$0.84

P/E Ratio

BIAFN/A

CELZN/A

P/S Ratio

BIAF6.23x

CELZ1,324.83x

EV/Sales

BIAF5.93x

CELZ-1,579.87x

EV/EBITDA

BIAF0.00x

CELZ0.00x

P/B Ratio

BIAF1.87x

CELZ0.72x

P/FCF Ratio

BIAFN/A

CELZN/A

EV/FCF

BIAF-3.02x

CELZ0.80x

PEG Ratio

BIAFN/A

CELZN/A

Forward P/E (NTM)

BIAFN/A

CELZN/A

Forward P/S (NTM)

BIAFN/A

CELZN/A

Revenue (TTM)

BIAF$6M

CELZ$3K

Revenue Growth (YoY)

BIAF-23.2%

CELZ-50.0%

Forward Rev Growth

BIAF0.0%

CELZ56.2%

Gross Margin (TTM)

BIAF34.6%

CELZ66.7%

Operating Margin (TTM)

BIAF0.0%

CELZ0.0%

EBITDA Margin (TTM)

BIAF-202.8%

CELZ-204213.3%

Net Margin (TTM)

BIAF-257.3%

CELZ-201356.7%

FCF Margin (TTM)

BIAF-196.0%

CELZ-196726.7%

Net Income (TTM)

BIAF$-15M

CELZ$-6M

FCF (TTM)

BIAF$-12M

CELZ$-6M

EPS (TTM)

BIAF-$43.57

CELZ-$1.63

ROE (TTM)

BIAF-25727.0%

CELZ-8670.0%

ROA (TTM)

BIAF-15954.0%

CELZ-8196.0%

ROIC (TTM)

BIAF-23305.0%

CELZ-8670.0%

Cash

BIAF$2M

CELZ$9M

Debt

BIAF$634K

CELZ$0

Net Cash/Debt

BIAF$2M

CELZ$9M

Current Ratio (TTM)

BIAF1.44x

CELZ12.91x

Quick Ratio (TTM)

BIAF1.36x

CELZ12.63x

Debt/Equity (TTM)

BIAF0.17x

CELZ0.00x

Debt/Assets (TTM)

BIAF0.0%

CELZ0.0%

Interest Coverage (TTM)

BIAFN/A

CELZN/A

Net Debt/EBITDA (TTM)

BIAF0.00x

CELZ0.00x

Beta

BIAF-1.26

CELZ1.93

52W Performance

BIAF-89.7%

CELZ-76.5%

YTD Performance

BIAF-74.2%

CELZ-57.4%

% from 52W High

BIAF-94.1%

CELZ-86.6%

% from 52W Low

BIAF3.6%

CELZ35.2%

Asset Turnover (TTM)

BIAF0.62x

CELZ0.00x

FCF Yield (TTM)

BIAF-31.5%

CELZ-148.5%

Earnings Yield (TTM)

BIAF-41.3%

CELZ-152.0%

Dividend Yield (TTM)

BIAFN/A

CELZN/A

Rule of 40

BIAF-219.2

CELZ-196,776.7

EV/GP/RG

BIAFN/A

CELZN/A

Ticker research

View BIAF research View CELZ research

Metric	BIAF bioAffinity Technologies Inc	CELZ Creative Medical Technology Holdings Inc
Market & Valuation
Market Cap	$37M	$4M
Enterprise Value	$35M	$-5M
Price	$4.73	$0.84
P/E Ratio	N/A	N/A
P/S Ratio	6.23x	1,324.83x
EV/Sales	5.93x	-1,579.87x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.87x	0.72x
P/FCF Ratio	N/A	N/A
EV/FCF	-3.02x	0.80x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$6M	$3K
Revenue Growth (YoY)	-23.2%	-50.0%
Forward Rev Growth	0.0%	56.2%
Profitability
Gross Margin (TTM)	34.6%	66.7%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-202.8%	-204213.3%
Net Margin (TTM)	-257.3%	-201356.7%
FCF Margin (TTM)	-196.0%	-196726.7%
Net Income (TTM)	$-15M	$-6M
FCF (TTM)	$-12M	$-6M
EPS (TTM)	-$43.57	-$1.63
ROE (TTM)	-25727.0%	-8670.0%
ROA (TTM)	-15954.0%	-8196.0%
ROIC (TTM)	-23305.0%	-8670.0%
Financial Health
Cash	$2M	$9M
Debt	$634K	$0
Net Cash/Debt	$2M	$9M
Current Ratio (TTM)	1.44x	12.91x
Quick Ratio (TTM)	1.36x	12.63x
Debt/Equity (TTM)	0.17x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-1.26	1.93
52W Performance	-89.7%	-76.5%
YTD Performance	-74.2%	-57.4%
% from 52W High	-94.1%	-86.6%
% from 52W Low	3.6%	35.2%
Efficiency & Yields
Asset Turnover (TTM)	0.62x	0.00x
FCF Yield (TTM)	-31.5%	-148.5%
Earnings Yield (TTM)	-41.3%	-152.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-219.2	-196,776.7
EV/GP/RG	N/A	N/A
Ticker research	View BIAF research	View CELZ research